Found: 12
Select item for more details and to access through your institution.
Identification of candidate diagnostic and prognostic biomarkers for human prostate cancer: RPL22L1 and RPS21.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Influence of ABCB1 polymorphisms on the pharmacokinetics and toxicity of lenalidomide in patients with multiple myeloma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Real-world study of afatinib in first-line or re-challenge settings for patients with EGFR mutant non-small cell lung cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Performance of a new system using a one-step nucleic acid amplification assay for detecting lymph node metastases in breast cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Correction to: Expression of Concern: Knockdown of eIF3d inhibits cell proliferation through G2/M phase arrest in non-small cell lung cancer.
- Published in:
- 2019
- By:
- Publication type:
- corrected article
Postmastectomy radiation therapy using VMAT technique for breast cancer patients with expander reconstruction.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Tumor expression and usefulness as a biomarker of programmed death ligand 1 in advanced non-small cell lung cancer patients with preexisting interstitial lung disease.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Intra- and inter-observer variability in breast tumour bed contouring and the controversial role of surgical clips.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Subgroup analysis of efficacy and safety of orantinib in combination with TACE in Japanese HCC patients in a randomized phase III trial (ORIENTAL).
- Published in:
- 2019
- By:
- Publication type:
- journal article
Timing of treatment in small-cell lung cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
N-Glycosylation in progression of skin cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Multicenter open-label randomized phase II study of second-line panitumumab and irinotecan with or without fluoropyrimidines in patients with KRAS wild-type metastatic colorectal cancer (PACIFIC study).
- Published in:
- 2019
- By:
- Publication type:
- journal article